Terug
Ook genoteerd als
MKGAF
OTC
Dagbereik
€ 23,79
€ 24,14
52-Weeksbereik
€ 23,76
€ 31,00
Volume
11.372
50D / 200D Gem.
€ 28,74
/
€ 27,03
Vorige Slotkoers
€ 23,90
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 20,8 | 0,4 |
| P/B | 1,8 | 2,9 |
| ROE % | 8,6 | 3,9 |
| Net Margin % | 12,4 | 3,8 |
| Rev Growth 5Y % | 0,7 | 10,0 |
| D/E | 0,4 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 2,20
€ 2,16 – € 2,25
|
25,33B | 1 |
| FY2029 |
€ 2,08
€ 2,05 – € 2,13
|
24,21B | 1 |
| FY2028 |
€ 1,89
€ 1,85 – € 1,93
|
22,98B | 1 |
No quarterly estimates available
Dividend History
Yield
0,02%
Payout Ratio
N/A
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 0,73% annually over 5 years — modest growth
Debt/Equity of 0,42 — conservative balance sheet
Generating 2,26B in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 4,92%
Cash machine — converts 90,03% of earnings into free cash flow
Capital efficient — spends only 7,51% of revenue on capex
Groei
Revenue Growth (5Y)
0,73%
Revenue (1Y)-4,19%
Earnings (1Y)-9,79%
FCF Growth (3Y)13,17%
Kwaliteit
Return on Equity
8,57%
ROIC7,22%
Net Margin12,36%
Op. Margin19,26%
Veiligheid
Debt / Equity
0,42
Current Ratio1,46
Interest Coverage15,52
Waardering
P/E Ratio
20,76
Forward P/EN/A
P/B Ratio1,82
EV/EBITDA15,68
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -4,19% | Revenue Growth (3Y) | -1,74% |
| Earnings Growth (1Y) | -9,79% | Earnings Growth (3Y) | -5,82% |
| Revenue Growth (5Y) | 0,73% | Earnings Growth (5Y) | -4,84% |
| Profitability | |||
| Revenue (TTM) | 20,27B | Net Income (TTM) | 2,51B |
| ROE | 8,57% | ROA | 4,81% |
| Gross Margin | 56,35% | Operating Margin | 19,26% |
| Net Margin | 12,36% | Free Cash Flow (TTM) | 2,26B |
| ROIC | 7,22% | FCF Growth (3Y) | 13,17% |
| Safety | |||
| Debt / Equity | 0,42 | Current Ratio | 1,46 |
| Interest Coverage | 15,52 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 20,76 | Forward P/E | N/A |
| P/B Ratio | 1,82 | P/S Ratio | 2,57 |
| PEG Ratio | -2,05 | Forward PEG | N/A |
| EV/EBITDA | 15,68 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 4,34% | ||
| Market Cap | 52,00B | Enterprise Value | 61,22B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20,27B | 21,16B | 20,99B | 22,23B | 19,69B |
| Net Income | 2,51B | 2,78B | 2,82B | 3,33B | 3,06B |
| EPS (Diluted) | 1,15 | 1,28 | 1,30 | 1,53 | 1,41 |
| Gross Profit | 11,42B | 12,49B | 12,39B | 13,71B | 12,34B |
| Operating Income | 3,90B | 3,65B | 3,61B | 4,47B | 4,18B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 52,08B | 51,57B | 48,50B | 48,53B | 45,36B |
| Total Liabilities | 23,43B | 21,58B | 21,74B | 22,52B | 23,95B |
| Shareholders' Equity | 28,58B | 29,91B | 26,68B | 25,93B | 21,34B |
| Total Debt | 11,96B | 10,27B | 9,86B | 10,40B | 10,77B |
| Cash & Equivalents | 2,74B | 2,15B | 1,98B | 1,40B | 1,51B |
| Current Assets | 13,22B | 13,45B | 12,39B | 12,20B | 10,98B |
| Current Liabilities | 9,04B | 11,29B | 8,70B | 9,51B | 10,43B |